OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2024 $1,365
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $1,365
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.954B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $171.942B 78.88
Thermo Fisher Scientific (TMO) United States $161.378B 19.56
Alcon (ALC) Switzerland $45.645B 30.34
Edwards Lifesciences (EW) United States $42.050B 27.30
IDEXX Laboratories (IDXX) United States $33.347B 38.56
DexCom (DXCM) United States $26.887B 41.56
IQVIA Holdings (IQV) United States $25.374B 14.04
STERIS (STE) Ireland $21.834B 24.97
Mettler-Toledo (MTD) United States $20.944B 24.42
Waters (WAT) United States $19.099B 27.04
SONOVA HOLDING (SONVY) Switzerland $17.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.878B 14.16
Hologic (HOLX) United States $12.916B 13.94
Sysmex ADR (SSMXY) Japan $11.847B 0.00
Penumbra (PEN) United States $10.729B 96.64
Globus Medical (GMED) United States $9.767B 22.61
Masimo (MASI) United States $8.221B 34.50
Teleflex (TFX) United States $6.004B 9.24
Glaukos (GKOS) United States $5.153B 0.00
Integer Holdings (ITGR) United States $4.081B 22.07
TransMedics (TMDX) United States $2.985B 87.37
PROCEPT BioRobotics (PRCT) United States $2.907B 0.00
Veracyte (VCYT) United States $2.427B 43.86
Nihon Kohden (NHNKY) Japan $2.081B 11.37
LivaNova (LIVN) United Kingdom $1.934B 11.74
Elekta AB (EKTAY) Sweden $1.891B 17.00
Alphatec Holdings (ATEC) United States $1.522B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.18
Pulse Biosciences (PLSE) United States $1.193B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Paragon 28 (FNA) United States $1.099B 0.00
Artivion (AORT) United States $0.979B 91.72
AxoGen (AXGN) United States $0.690B 0.00
IRadimed (IRMD) United States $0.658B 34.51
Mesa Laboratories (MLAB) United States $0.609B 13.30
SiBone (SIBN) United States $0.588B 0.00
RxSight (RXST) United States $0.584B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 9.21
OrthoPediatrics (KIDS) United States $0.510B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.508B 0.00
Beta Bionics (BBNX) United States $0.483B 0.00
Treace Medical Concepts (TMCI) United States $0.406B 0.00
Delcath Systems (DCTH) United States $0.389B 0.00
AngioDynamics (ANGO) United States $0.387B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
ClearPoint Neuro (CLPT) United States $0.342B 0.00
Tactile Systems Technology (TCMD) United States $0.315B 16.87
Semler Scientific (SMLR) United States $0.312B 6.62
Neuronetics (STIM) United States $0.247B 0.00
Inogen (INGN) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.181B 0.00
908 Devices (MASS) United States $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
LENSAR (LNSR) United States $0.164B 0.00
CVRx (CVRX) United States $0.163B 0.00
Accuray (ARAY) United States $0.152B 0.00
Sight Sciences (SGHT) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.104B 0.00
Anteris Technologies Global (AVR) Australia $0.104B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.076B 11.48
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00